Clinical and molecular factors predictive of response and survival in patients with myelofibrosis treated with ruxolitinib (SIE 2026) - Oct 6, 2026 - Pres time: Sep 22, 2026; 05:20 PM - 06:20 PM; Location: HALL 2; No abstract available
Clinical • Myelofibrosis
|